Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion type Assertion NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_head.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion description "[We found that patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival (RF-CSS): HR=1.26; 95% CI: 1.15-1.60; P<0.001.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_provenance.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion evidence source_evidence_literature NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_provenance.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion SIO_000772 23011541 NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_provenance.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion wasDerivedFrom befree-20150227 NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_provenance.
- NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_assertion wasGeneratedBy ECO_0000203 NP997961.RA2ngKWic5xUkwUNvSoyYHQgZcaaWygfTfG6wU16E7sCY130_provenance.